By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Clovis Oncology 

1871 Folsom Street

Boulder  Colorado  80302  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS








Company News
Clovis Oncology (CLVS) To Announce Second Quarter 2015 Financial Results And Host Webcast Conference Call On August 6 7/24/2015 11:01:38 AM
Clovis Oncology (CLVS) Announces Exercise In Full Of Underwriters’ Option To Purchase Additional Shares Of Common Stock 7/10/2015 9:44:15 AM
Clovis Oncology (CLVS) Announces Pricing Of Public Offering Of Common Stock 7/9/2015 8:07:06 AM
Clovis Oncology (CLVS) Raising $275 Million to Develop Cancer Drug Pipeline 7/8/2015 6:21:27 AM
Clovis Oncology (CLVS) Initiates Rolling NDA Submission To The FDA For Rociletinib In The Treatment Of Advanced EGFR-Mutant Non-Small Cell Lung Cancer 7/2/2015 9:53:49 AM
Clovis Oncology (CLVS)’s CMO Quits Abruptly to Launch Own Immuno-Oncology Company 6/23/2015 8:31:58 AM
Clovis Oncology (CLVS) Appoints Dr. Lindsey Rolfe As Chief Medical Officer 6/22/2015 12:04:13 PM
Clovis Oncology (CLVS)’s Rociletinib (CO-1686) Phase 2 Study Results Demonstrate Consistent And Promising Clinical Activity And Disease Control In Very Advanced Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) 6/1/2015 12:19:30 PM
ASCO15: Clovis Oncology (CLVS)’s Rociletinib (CO-1686) Phase II Study Results Demonstrate Consistent And Promising Clinical Activity And Disease Control In Very Advanced Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC 6/1/2015 6:18:33 AM
ASCO15: Tiny Clovis Oncology (CLVS) Becomes an Even Bigger Takeover Target as Ovarian Cancer Drug Shrunk Tumors in 82% of Women 6/1/2015 6:16:33 AM
12345678910...
//-->